Results 91 to 100 of about 18,201 (186)

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page 1344-1358, August 2026.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore   +8 more
wiley   +1 more source

Paraneoplastic Syndromes

open access: yesBrain Pathology, 1999
Giometto B, Scaravilli F
openaire   +4 more sources

Paraneoplastic Adult‐Onset Still's Disease Caused by Mediastinal Lymph Node Carcinoma of Unknown Primary Site, Most Likely Lung Adenocarcinoma

open access: yes
International Journal of Rheumatic Diseases, Volume 29, Issue 8, August 2026.
Yoshinori Taniguchi, Daiki Okada
wiley   +1 more source

Altered exosomal miRNA profiles in patients with paraneoplastic cerebellar degeneration

open access: yesAnnals of Clinical and Translational Neurology
Objective Patients with ovarian cancer (OC) may develop anti‐Yo‐associated paraneoplastic cerebellar degeneration (PCD)—a cerebellar ataxia associated with tumor‐induced autoimmunity against CDR2 and CDR2L proteins.
Eirik Tveit Solheim   +7 more
doaj   +1 more source

Single-Center Retrospective Analysis of Paraneoplastic Syndromes with Peripheral Nerve Damage. [PDF]

open access: yesBrain Sci, 2022
Tian J   +8 more
europepmc   +1 more source

Multiple Paraneoplastic Syndromes [PDF]

open access: yesJournal of the Royal Society of Medicine, 1986
A F, Broomhead   +2 more
openaire   +2 more sources

Clinical characteristics of paraneoplastic syndromes in patients with head and neck cancer. [PDF]

open access: yesLaryngoscope Investig Otolaryngol, 2022
Diao W   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy